Research Article

Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification

Figure 4

Protection of aging myocardial cells from hypoxia/reoxygenation (H/R) injury by dexmedetomidine (Dex) was enhanced by miR-29b-3p overexpression. Cell apoptosis was evaluated by flow cytometry. (a) Expression of miR-29b-3p after exposure to different concentrations of Dex and hypoxia postconditioning was detected by RT-PCR (, ; vs. the H/R group). (b) Expression of miR-29b-3p in senescent cardiomyocytes, which were subjected to H/R treatment within 48 h of transfection with miR-29b-3p mimics or NC, as well as 6 h Dex postconditioning. (c) Cell viability was evaluated using a CCK-8 assay. (d) Expression of Bcl-2 and Bax was evaluated by western blotting. , ; , #.
(a)
(b)
(c)
(d)